News, Links and Commentary
Tuesday, February 08, 2005
Macugen / Pegaptanib Drug Treatment For Wet AMD
A potential drug treatment for the wet form of age-related macular degeneration, pegaptanib sodium injection (also known as Macugen), was reviewed in the December 30 issue of the New England Journal of Medicine.
An abstract is available online for the review, titled 'Pegaptanib for Neovascular Age-Related Macular Degeneration' (Evangelos S. Gragoudas and others, New England Journal of Medicine, December 30 2004, Volume 351, pages 2805-2816).
In two clinical trials at 117 sites in the United States, Canada, Europe, Australia and South America, doctors found that people treated with the drug early in their illness lost less vision over a one-year period than those who went untreated.
'Rays of hope for macular degeneration' (LA Times, 7 February 2005).
An abstract is available online for the review, titled 'Pegaptanib for Neovascular Age-Related Macular Degeneration' (Evangelos S. Gragoudas and others, New England Journal of Medicine, December 30 2004, Volume 351, pages 2805-2816).
Comments:
Post a Comment
